Form 4: Aspira Women's Health President Acquires 25,000 Stock Options

Aspira Women's Health President, Sandra Milligan, acquired 25,000 stock options at an exercise price of $0.84 on November 12, 2024.

Summary

• Sandra Milligan, President of Aspira Women's Health Inc., has reported the acquisition of 25,000 stock options.
• The transaction occurred on November 12, 2024.
• The exercise price for these options is $0.84 per share.
• The options are exercisable immediately and expire on November 12, 2034.
• The underlying security for these options is 25,000 shares of Aspira Women's Health Inc. common stock.

Sentiment

Score: 6

Explanation: The document is a routine disclosure of stock option grants, which is neither particularly positive nor negative. It indicates standard executive compensation practices.

Positives

• The acquisition of stock options by a company president can be seen as a positive sign of confidence in the company's future performance.

Industry Context

This is a routine disclosure of stock option grants to a company executive, which is common practice in publicly traded companies as part of executive compensation packages.

Comparison to Industry Standards

• Stock option grants are a standard form of compensation for executives in publicly traded companies, particularly in the healthcare and biotechnology sectors.
• The exercise price of $0.84 is specific to Aspira Women's Health and would need to be compared to similar companies to assess its relative value.
• The 10-year expiration period is also typical for stock options.

Stakeholder Impact

• The acquisition of stock options by the President may be viewed positively by shareholders as it aligns her interests with the company's performance.

Key Dates

Keywords

stock options, insider trading, executive compensation, Aspira Women's Health, Sandra Milligan